Odyssey Therapeutics, Inc. (ODTX)
Odyssey Therapeutics, Inc. (ODTX)
| Balance Sheets | 2026-06-30 | 2026-03-31 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 82,031 | 35,719 | ||
| Short-term marketable securities | 228,544 | 140,030 | ||
| Prepaid expenses and other current assets | 10,887 | 9,352 | ||
| Total current assets | 321,462 | 185,101 | ||
| Property, plant and equipment, gross | 17,912 | 21,663 | ||
| Less accumulated depreciation | 13,036 | 15,107 | ||
| Property and equipment, net | 4,876 | 6,556 | ||
| Right-of-use assets | 17,040 | 17,920 | ||
| Goodwill | 14,100 | 14,072 | ||
| Intangible asset | 86 | 160 | ||
| Long-term marketable securities | 122,494 | 0 | ||
| Other non-current assets | 3,792 | 5,261 | ||
| Total assets | 483,850 | 229,070 | ||
| Accounts payable | 7,668 | 8,219 | ||
| Accrued expenses and other current liabilities | 15,162 | 8,618 | ||
| Lease liabilities, current | 5,465 | 5,374 | ||
| Total current liabilities | 28,295 | 22,211 | ||
| Contingent consideration and warrant liability | 14,974 | 6,242 | ||
| Lease liabilities, non-current | 19,360 | 20,753 | ||
| Total liabilities | 62,629 | 49,206 | ||
| Convertible preferred stock-Series APreferred Stock | 0 | 216,503 | ||
| Convertible preferred stock-Series BPreferred Stock | 0 | 167,765 | ||
| Convertible preferred stock-Series CPreferred Stock | 0 | 123,259 | ||
| Convertible preferred stock-Series DPreferred Stock | 0 | 196,031 | ||
| Common stock, 0.0001 par value 500,000,000 and 365,081,240 shares authorized as of june 30, 2026 and december 31, 2025 respectively 48,031,320 shares and 2,472,757 shares issued as of june 30, 2026 and december 31, 2025, respectively 47,891,251 shares and 2,306,207 shares outstanding as of june 30, 2026 and december 31, 2025, respectively | 5 | - | ||
| Additional paid-in capital | 1,080,910 | 82,854 | ||
| Accumulated deficit | -659,189 | -606,401 | ||
| Accumulated other comprehensive income (loss) | -505 | -147 | ||
| Total stockholders' equity (deficit) | 421,221 | -523,694 | ||
| Total liabilities, convertible preferred stock, and stockholders' equity (deficit) | 483,850 | 229,070 | ||